Patient-experience themes¶
Each theme is supported by at least two independent public or peer-reviewed sources. Themes describe recurring concerns; they do not estimate prevalence.
1. Diagnostic uncertainty and invalidation¶
People with ongoing angina can struggle when stenosis severity, ischemia tests, and symptoms do not align. INOCA adds a specific invalidation pathway: non-obstructive angiography may be communicated as absence of disease even when CMD or vasospasm is present. CorMicA shows that a mechanistic diagnosis linked to therapy improves symptoms and quality of life (Ford 2018, PMID 30266608); INOCA International's patient resources center delayed recognition and access to knowledgeable care (INOCA International — patient resources, https://inocainternational.com/patients/, accessed 2026-08-30).
2. Fear of recurrence and fear of activity¶
After MI, ordinary exertional sensations can be interpreted as warning signs, producing avoidance and deconditioning. Qualitative research documents kinesiophobia and uncertainty about safe exercise (Bäck 2020, PMID 32886775). The Australian Heart Foundation explicitly frames worry, confusion, supervised CR, and knowing warning signs as linked recovery needs (Heart Foundation — “Heart attack recovery — your next steps,” https://www.heartfoundation.org.au/your-heart/support/heart-attack-recovery-next-steps, accessed 2026-08-30).
3. Psychological distress is part of cardiac recovery¶
Depression, anxiety, and PTSD symptoms are common after acute MI in meta-analysis (Chong 2025, PMID 40142595). Heart & Stroke Canada treats emotions, relationships, peer community, and recovery education as core patient resources rather than peripheral content (Heart & Stroke Foundation — “Recovery & support,” https://www.heartandstroke.ca/heart-disease/recovery-and-support, accessed 2026-08-30).
4. Medication burden and ambivalence¶
Patients may leave hospital with multiple new drugs, limited understanding of purpose/duration, bruising or symptoms, and refill/cost barriers. SECURE shows that regimen simplification can improve adherence and reduce MACE (Castellano 2022, PMID 36018037). Mended Hearts provides peer support and structured patient education across recovery, illustrating demand for explanations beyond the discharge encounter (Mended Hearts — “About us,” https://mendedhearts.org/about-us/, accessed 2026-08-30).
5. Rehabilitation access is a chain, not a referral¶
CR reduces cardiovascular mortality and hospitalization (Dibben 2023, PMID 36746187), yet qualitative studies document travel, scheduling, knowledge, fear, and service barriers in different health systems (Borah 2023, PMID 37033594; Xie 2022, PMID 36447215). BHF and the Australian Heart Foundation offer home/digital or directory-based support, reflecting patient demand for multiple delivery modes (BHF — support, https://www.bhf.org.uk/informationsupport/support, accessed 2026-08-30; Heart Foundation Australia recovery page, accessed 2026-08-30).
6. Sex/gender affects recognition and legitimacy¶
Women commonly have chest pain in ACS, but accompanying symptom differences and biased “atypical” framing can delay recognition (van Oosterhout 2020, PMID 32363989). WomenHeart's mission explicitly combines education, support, timely diagnosis and advocacy for women with or at risk of heart disease (WomenHeart, https://www.womenheart.org/, accessed 2026-08-30).
7. Peer support fills a continuity gap¶
Mended Hearts provides chapters, groups and hospital visiting by people with lived experience; Heart & Stroke Canada offers survivor community and recovery resources (Mended Hearts, https://mendedhearts.org/about-us/; Heart & Stroke Canada, https://www.heartandstroke.ca/heart-disease/recovery-and-support; accessed 2026-08-30). Peer support may reduce isolation and normalize recovery questions, but comparative outcome evidence and safeguards require further study.
8. Patients prioritize function and certainty as well as survival¶
ORBITA-2 shows that PCI can reduce angina versus placebo, while symptom-predictor analysis shows heterogeneous response (Rajkumar 2023, PMID 38015442; Simader 2024, PMID 38759906). These data support patient priorities—walking, working, sleeping, caregiving—without confusing symptom benefit with infarct prevention.
Cross-cutting research gaps¶
- Validated measures of diagnostic invalidation and uncertainty.
- CR trials powered for access equity and completion, not enrollment alone.
- Peer-support effectiveness and potential misinformation harms.
- Patient-reported medication burden linked to adherence and events.
- Representative qualitative work in LMICs and non-English languages.